Presentation is loading. Please wait.

Presentation is loading. Please wait.

PHARMACOLOGY I. PRIMARY PROBLEM II. THERAPEUTIC GOALS III. MANAGEMENT

Similar presentations


Presentation on theme: "PHARMACOLOGY I. PRIMARY PROBLEM II. THERAPEUTIC GOALS III. MANAGEMENT"— Presentation transcript:

1 PHARMACOLOGY I. PRIMARY PROBLEM II. THERAPEUTIC GOALS III. MANAGEMENT
PHARMACOLOGIC NON PHARMACOLOGIC

2 PRIMARY PROBLEM Iron Deficiency Anemia
In normal menstruating women, iron requirements are increased. Cause of iron deficiency anemia is probably due to heavy bleeding during menstruation The severity and cause of iron-deficiency anemia will determine the appropriate approach to treatment

3 THERAPEUTIC GOALS The goal of therapy in individuals with iron deficiency anemia is: To repair the anemia through Oral Iron Therapy Parenteral Iron therapy Adequate dietary intake of iron To provide iron stores To regulate bleeding due to heavy blood flow during menstruation

4 MANAGEMENT Pharmacologic Management of Iron Deficiency Anemia
Oral Iron Therapy Ferrous sulfate, Ferrous gluconate, Ferrous fumarate Supplemental iron is needed to replenish lost iron stores Ferrous iron is most easily absorbed Treatment with oral iron should be continued for 3-6 months to correct the anemia and replenish iron stores

5 Commonly used Oral Iron Preparations
Tablet size Elemental iron/tablet Usual Adult Dosage (tablets/day) Ferrous sulfate hydrated dessicated 325 mg 200 mg 65 mg 3-4 Ferrous gluconate 36 mg Ferrous fumarate 106 mg 2-3 Ferrous sulfate, ferrous gluconate and ferrous fumarate are all effective and inexpensive. Ferrous sulfate – most inexpensive Table 33-2 Katzung, B. Basic and Clinical Pharmacology, 9th Ed. McGraw-Hill: New York

6 Parenteral Iron Therapy
Reserved for patients with documented iron deficiency who are unable to tolerate or absorb oral iron and patients with extensive chronic blood loss who cannot be maintained on oral iron alone. Postgastrectomy Previous small bowel resection Inflammatory bowel disease Malabsorption syndrome

7 Parenteral Iron Therapy
Iron Dextran (IV or IM) Stable complex of ferric hydroxide and low molecular weight Dextran (50mg of elemental iron) Iron-sucrose complex and Iron Sodium gluconate complex (IV) Alternative preparations IV administration eliminates local pain and tissue staining that often occur with IM

8 Parenteral Iron Therapy
Iron gluconate has less allergic reactions as compared to Iron dextran Iron sucrose also has less side effects, even if there is a prior history of rxn to Iron dextran Iron dextran – risk of hypersensitivity reaction Small test dose of iron dextran should always be given before full IM or IV doses are given. Faich, G. Am J Kidney Dis 1999; 33:464

9 MANAGEMENT Non-Pharmacologic Management of Iron Deficiency Anemia
Increase intake of iron from foods such as liver, lean meats, beans, peas, tofu, dark green & leafy vegetables, and egg yolks. Stopler T (2004). Medical nutrition therapy for anemia. In LK Mahan, S Escott-Stump, eds., Krause's Food, Nutrition and Diet Therapy, 11th ed., pp. 838–859. Philadelphia: Saunders.

10 MANAGEMENT Pharmacologic Management of heavy bleeding during menstruation Hormonal Treatment OCP GnRH agonist Schorge J. et al(2008). Wiliams Gynecology

11 Thank You!


Download ppt "PHARMACOLOGY I. PRIMARY PROBLEM II. THERAPEUTIC GOALS III. MANAGEMENT"

Similar presentations


Ads by Google